Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Pharmacognosy and Pharmaceutical Research

Vol. 6, Issue 2, Part A (2024)

Assessing guidelines for diabetes management in hypertension

Author(s):

Ladli Kishore and Abhay Mehta

Abstract:

Among the main comorbidities if diabetes, hypertension causes both macrovascular and microvascular problems as well as a large amount of death and disability. Individuals with diabetes plus hypertension are twice as likely to die from cardiovascular causes as those with diabetes alone. That should be mentioned that blood pressure management has been demonstrated to help with these issues. Research finds that a 10% reduction in systolic blood pressure results with a 15 percent reduction in diabetes-related mortality, a 12% decrease in diabetes-related comorbidities, and an 11% decrease for myocardial infarctions. Therefore, it wouldn't be reasonable to think that treating hyperglycemia alone will reduce these individuals' two to four-fold elevated likelihood of cardiovascular death. Thereby, the study's goal was to look at several intervention articles that may significantly improve treatment outcomes when used in conjunction with the text's discussed non-pharmacological, pharmacological, antioxidant, and herbal antihypertensive treatment approaches.

Pages: 32-36  |  141 Views  56 Downloads


International Journal of Pharmacognosy and Pharmaceutical Research
How to cite this article:
Ladli Kishore and Abhay Mehta. Assessing guidelines for diabetes management in hypertension. Int. J. Pharmacogn. Pharm. Res. 2024;6(2):32-36. DOI: 10.33545/26647168.2024.v6.i2a.75
Call for book chapter